Curis
CRIS
#10209
Rank
S$19.24 M
Marketcap
S$1.41
Share price
-2.63%
Change (1 day)
-65.99%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.65. In 2024 the company made an earnings per share (EPS) of S-$8.90 an increase over its 2023 EPS that were of S-$11.43.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-45.24%
2024S-$8.90-22.15%
2023S-$11.43-26.17%
2022S-$15.4922.3%
2021S-$12.66-25.37%
2020S-$16.97-30.93%
2019S-$24.56-2.02%
2018S-$25.07
2016S-$56.98-10%
2015S-$63.31138.1%
2014S-$26.5940%
2013S-$18.99-25%
2012S-$25.3266.67%
2011S-$15.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.72-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.76-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.01-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.28-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.23 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.79-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA